A research team at Seoul National University Hospital has discovered a new biomarker that can diagnose Moyamoya Disease (MMD), a childhood cerebrovascular disease, early and predict the treatment ...

SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for ...

Stroke remains one of the leading causes of mortality and long-term disability worldwide, imposing a significant burden on individuals, healthcare systems, ...

The THR‑β agonist market is witnessing rapid growth, fueled by the increasing global prevalence of metabolic disorders such as MASH and rare genetic ...

This IND clearance represents a major milestone for EuMentis as we advance EM–221 through Phase 2 clinical development,” said ...

Recent advances in computational protein design have depended mainly on neural networks and machine learning to generate ...

A group of Australian scientists has uncovered a new way to fight some of the toughest cancers by targeting an overlooked ...

Insulin resistance is a hallmark of multiple metabolic disorders, including type 2 diabetes, obesity, metabolic syndrome, and polycystic ovary syndrome. It ...

Bentham Science presents Promising Cancer Therapeutic Drug Targets: Recent Advancements, a timely and in-depth resource on the latest strategies in cancer treatment. This comprehensive volume presents ...

Non-small cell lung cancer (NSCLC) accounts for over 80% of lung cancer cases and is often diagnosed at advanced stages, ...

Children who develop deep wrinkles, stunted growth, and rapidly aging bones and blood vessels as early as 1 to 2 years of age ...

New designer proteins created using an AI tool can selectively target peptide segments that bind to markers on diseased ...